World Pancreatic Cancer Coalition (WPCC) and American Association for Cancer Research (AACR) Pancreatic Cancer Special Conference brought together patient advocacy groups and outstanding professionals 10-15 May, 2016 in Orlando, Florida to discuss pancreatic cancer, a disease with the lowest survival rates of any major cancer Prof Borrebaeck presented in his AACR talk how serum biomarker signatures can detect early stages of pancreatic cancer LUND, Sweden - The days between 10 to 15 of May, 2016 were dedicated to the deadliest form of cancer, pancreatic cancer, by two major events that took place in Orlando, USA: the first World Pancreatic Cancer Coalition (WPCC) followed by the third AACR Pancreatic Cancer Special Conference. Both events represented major breakthroughs for Immunovia and IMMray™ PanCan-d as the following main areas in pancreatic cancer were emphasized: Firstly, the largest global patient advocacy pancreatic cancer coalition was formed to provide a united front against this lethal disease. Immunovia sponsors the patient advocacy world coalition and will work closely with the members on both national and global levels. Secondly, the main focus of pancreatic cancer care is now clearly early detection of stages I & II for improved chances of patient survival. Prof Borrebaeck’s talk presented clinical studies results covering over 2500 pancreatic cancer blood samples that show that IMMray™ PanCan-d can detect stages I, II, III and IV patients with an accuracy of 98%. The Scandinavian study that was finalized last year, was presented for the first time at this event and the data (that were initially press released in Nov 2015: link (http://immunovia.com/immray-pancan-d-detects-98-of-pancreatic-cancers-in -retrospective-study-with-1400-blood-samples/)) showed that Immunovia’s test is able to detect the early stages of pancreatic cancer in blood with unprecedented accuracy of 96%. The talk received fantastic response from the conference participants and particularly from Key Opinion Leaders. Thirdly, the high risk group of late onset diabetes after 50 years of age was strongly brought forward as an area that needs immediate and increased priority. Immunovia has commenced discussions to participate in the late onset diabetes programs underway. To read the complete summary from the WPCC and AACR Pancreatic Cancer Special Conference in Orlando, click here (PDF). 2 0 16-05-30 Laura Chirica, PhD, Immunovia, Sweden
Double pancreatic cancer survival by 2020 World Pancreatic
Top 10 Most Recent News Articles
First-Time Clermont Homebuyers Face Unexpected Hurdles
Welcome to the Wild Ride of Buying a Home! When folks step into the homebuying ring, especially in places like Clermont, Florida, they often don't realize how chaotic things can get. It's like being thrown into a boxing match without gloves. Brandie Mathison-Klein from the Mathison-Klein Group shines a light on this in a HelloNation piece, spilling the beans on what...
Continue Reading
Hybrid Bonding Market Shooting to $2.45 Billion by 2033
Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...
Continue Reading
Pine AI Unveils AI Studio & Real-World Call Feature
Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...
Continue Reading
Sasol Names Stanley Subramoney as Audit Chair
Shifting Sands at Sasol's Audit Helm Ah, the boardroom dance continues. Sasol has just announced, loud and clear from Johannesburg, that Mr. Stanley Subramoney is stepping up as the new Chairman of their Audit Committee. This is no small shuffle in the deck. When it comes to keeping the books in check at big players like Sasol, you need a top-tier audit leader. Ain't no...
Continue Reading
Timken Maintains Robust Dividend Streak in 2026
Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...
Continue Reading
IM Cannabis's Third Quarter Financial Jolt
IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...
Continue Reading
TIGR Investors Eye Class Action Amid Legal Woes
A Legal Storm Brews Over UP Fintech When it rains, it pours, and for UP Fintech Holding Limited, the sky's looking pretty stormy. Investors who jumped on the NASDAQ:TIGR bandwagon between April 2024 and June 2026 are finding themselves at the center of a nasty legal maelstrom. The allegations? Well, they're explosive, hinting at a pattern of unlicensed cross-border...
Continue Reading
CVRx Faces Legal Storm: Investors Grapple with Fallout
CVRx in the Crosshairs: Legal and Operational Woes There's a storm brewing over at CVRx, Inc. (NASDAQ: CVRX), and it's pulling investors down a hell of a financial rabbit hole. You might think you're in the clear with a company like CVRx that boasts approved devices, but think again. Recent revelations have shown that even those with FDA stamps aren't immune to the...
Continue Reading
Finding the Right Auto Insurance: What to Consider
Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...
Continue Reading
Class Action Looms Over The Chemours Company
Chemours Under Fire: What’s Happening? Here we are, in the thick of a legal storm surrounding The Chemours Company. A class-action lawsuit is underway, and it’s painting the company in a rather unflattering light. Now, if you snagged some of that NYSE:CC action between February 20, 2026, and August 4, 2026, there's a chance you’re caught in the crossfire. Per the...
Continue ReadingTop 5 Most Recently Viewed Articles
Cango Inc. Reports Impressive Bitcoin Production Growth
Cango Inc. Performs Exceptionally in Bitcoin Mining Operations Cango Inc. has seen remarkable progress in its Bitcoin mining endeavors, as showcased by its recent production report. The company operates using a well-structured strategy, which has proven successful in driving growth within the cryptocurrency market. Key Metrics to Note The September report illustrates the...
Continue Reading
BWXT Awarded Deconversion Contract by U.S. DOE for HALEU
BWXT's Achievement in Nuclear Fuel Deconversion Rich in innovation and commitment to nuclear solutions, BWX Technologies, Inc. (NYSE: BWXT) has recently announced a significant achievement. Their Nuclear Fuel Services, Inc. (NFS) division has been selected by the U.S. Department of Energy (DOE) as part of a prominent initiative. This recognition places BWXT at the...
Continue Reading
SEALSQ Showcases Quantum-Resistant Solutions at Quantum Days
SEALSQ Showcases Quantum-Resistant Solutions at Quantum Days During a recent event, SEALSQ Corp (NASDAQ: LAES), a leader in semiconductor and post-quantum technology, demonstrated its commitment to cutting-edge security solutions. The event showcased live demonstrations highlighting the effectiveness of post-quantum cryptography (PQC) through their implementation of two...
Continue Reading
Ultragenyx Pharmaceutical Grants Stock Units to New Officers
Ultragenyx Pharmaceutical Welcomes New Team Members Novato, California - Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a dedicated biopharmaceutical entity, proudly reports the issuance of 20,820 restricted stock units to 13 newly hired non-executive officers as part of their employment inducement initiative. This decision, approved by the company's compensation...
Continue Reading
Alto Neuroscience Faces Class Action Amid Allegations of Fraud
Alto Neuroscience Faces Class Action Lawsuit for Securities Issues In recent developments, Alto Neuroscience, Inc. finds itself at the center of a class action lawsuit alleging securities fraud, with significant implications for its investors. The lawsuit, spearheaded by prominent legal firm Levi & Korsinsky, LLP, aims to secure compensation for stockholders negatively...
Continue Reading